Pages
- About
- Careers
- Clinical Support
- Abdo, 2026 (Addressing Infection Risk)
- Chaparala et al., 2025 (Epidermal Autografts)
- Detail Aids
- Flores, 2026 (Burn Wound Management)
- Flores, 2026 (Limb Salvage)
- Flores, 2026 (Management of Complex Infected Wounds)
- Flores, 2026 (NSTI)
- Hurn et al. (High-Risk Arthroplasty Patients)
- Paladugu, 2026 (Burn Autograft Donor Site Pain)
- Pranami et al., 2026 (SAMatrix™ with PainGuard®)
- Price, 2026 (Pain Relief in Complex Wounds)
- Schurr et al., 2025 (Infection Risk and Pain in Burns)
- Schurr et al., 2026 (Epidermal Autograft)
- Weaver, 2026 (Managing Pain in Pediatric Patients)
- Webinars/Video Interviews
- Contact us
- Distributors
- Frequently Asked Questions (FAQ)
- Imbed Biosciences – Homepage
- Patients
- Privacy Policy
- Providers
- SAMatrix™ Antimicrobial Technology
- Sitemap
- Terms and Conditions
Posts by category
- Category: Billing and Coding
- Category: Press Releases
- Imbed Biosciences Launches Dual-Action Wound Matrix Integrating Bioburden Management and Pain Relief in a Single Solution
- Imbed Biosciences Announces FDA IDE Approval for Silver-Gallium Synthetic Antimicrobial Matrix Clinical Study with Human Donor Site Wounds
- Imbed Biosciences Receives FDA 510(s) Clearance for Microlyte® Ag/Lidocaine
- Imbed Biosciences, Inc awarded Skin Integrity and Wound Care agreement with Premier, Inc.
- Niterra Leads $10M Growth Funding Round for Imbed Biosciences
- Category: Uncategorized
Jobs
Events
- 13th Annual Northeast Region Burn Conference
- Boswick Burn and Wound Care Symposium 2027
- 2026 Midwest Regional Burn Conference
- SAWC Fall 2026
- 2026 ISBI Congress
Products
- SAMatrix™ PainGuard® with Lidocaine
- Microlyte® - Wounds
- Pelashield® - Burn and Acute Wounds
- Surgaflex®- Surgical Wounds
Videos
- Patient describes SAM™ Antimicrobial Matrix treatment after motorcycle accident
- Diabetic patient describes SAM™ Antimicrobial Matrix treatment Staph-infected heel abrasion